These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7337665

  • 21. [Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin].
    Ehrly AM.
    Med Welt; 1975 Mar 07; 26(10):446-55. PubMed ID: 1123988
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Incidence of peptic ulcer in an inpatient angiologic patient sample].
    Creutzig A, Horstkotte H, Fischer M, Kleine P, Brunner G, Alexander K.
    Leber Magen Darm; 1984 Jul 07; 14(4):161-3. PubMed ID: 6482641
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prevention of experimental postoperative adhesions by ancrod defibrinogenation.
    Buckman RF, Bordos D, Bell WR, Cameron JL.
    J Surg Res; 1975 Apr 07; 18(4):377-84. PubMed ID: 1142753
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Pharmacological treatment of chronic arterial occlusive disease (author's transl)].
    Dittrich J, Spaan G, Stein U, Wagner E, Frese JH.
    Med Klin; 1979 Sep 28; 74(39):1396-403. PubMed ID: 492058
    [Abstract] [Full Text] [Related]

  • 28. [Arvin--a new therapeutic agent].
    Ehrly AM.
    Med Welt; 1978 Jul 14; 29(27-28):1144-5. PubMed ID: 672584
    [No Abstract] [Full Text] [Related]

  • 29. Functional outcome of discordant xenoislet grafts from a large animal donor after recipient defibrinogenation with Ancrod.
    Troppmann C, Zhang K, Gruessner AC, West M, Gruessner RW.
    Transplant Proc; 1997 Jun 14; 29(4):2170-2. PubMed ID: 9193575
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Defibrinogenating enzymes.
    Bell WR.
    Drugs; 1997 Jun 14; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Indication for arvin therapy from a surgical viewpoint].
    Stockmann U.
    ZFA (Stuttgart); 1978 Nov 20; 54(32):1652-3. PubMed ID: 735321
    [No Abstract] [Full Text] [Related]

  • 38. [Therapeutic defibrination by arwin in unstable angina pectoris combined with hyperfibrinogenaemia (author's transl)].
    Spöttl F, Pimmingstorfer E, Froschauer J.
    Wien Klin Wochenschr; 1978 Nov 24; 90(22):792-6. PubMed ID: 716435
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ancrod as prophylaxis or treatment for thromboembolism in patients with multiple trauma.
    Cole CW, Shea B, Bormanis J.
    Can J Surg; 1995 Jun 24; 38(3):249-54. PubMed ID: 7788603
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.